Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Robinson

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Molecular Cancer Therapeutics|November 1, 2022
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In VivoBarbara Jonchere, Justin Williams, Frederique Zindy, et al.
Annals of Clinical and Translational Neurology|February 8, 2021
Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathiesChiseko Ikenaga, Andrew R Findlay, Namita A Goyal, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Frontiers in Health Services|August 28, 2023
What interventions should we implement in England's mental health services? The mental health implementation network (MHIN) mixed-methods approach to rapid prioritisationShalini Ahuja, Lawrence Phillips, Caroline Smartt, et al.
Science Advances|January 30, 2018
Saigas on the brink: Multidisciplinary analysis of the factors influencing mass mortality eventsRichard A Kock, Mukhit Orynbayev, Sarah Robinson, et al.
Science Advances|April 15, 2026
Patient-derived pediatric brain tumor orthotopic xenografts and tumor organoids faithfully recapitulate primary tumorsJustin S Williams, Dana M Farmer, Qianqian Li, et al.
NPJ Parkinson'S Disease|November 7, 2025
Mapping the developmental path for Parkinson's disease therapeuticsNeel T Dhruv, Sarah Robinson Schwartz, Christine Swanson-Fischer, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 22, 2023
The Effect of the COVID-19 Pandemic on HbA1c Testing: Prioritization of High-Risk Cases and Impact of Social DeprivationDavid Holland, Adrian H Heald, Fahmy F W Hanna, et al.
JMIR Research Protocols|May 5, 2023
Impact of California's Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline DataAna Florea, Joan A Casey, Keeve Nachman, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Molecular Cancer Therapeutics|November 1, 2022
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In VivoBarbara Jonchere, Justin Williams, Frederique Zindy, et al.
Annals of Clinical and Translational Neurology|February 8, 2021
Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathiesChiseko Ikenaga, Andrew R Findlay, Namita A Goyal, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Frontiers in Health Services|August 28, 2023
What interventions should we implement in England's mental health services? The mental health implementation network (MHIN) mixed-methods approach to rapid prioritisationShalini Ahuja, Lawrence Phillips, Caroline Smartt, et al.
Science Advances|January 30, 2018
Saigas on the brink: Multidisciplinary analysis of the factors influencing mass mortality eventsRichard A Kock, Mukhit Orynbayev, Sarah Robinson, et al.
Science Advances|April 15, 2026
Patient-derived pediatric brain tumor orthotopic xenografts and tumor organoids faithfully recapitulate primary tumorsJustin S Williams, Dana M Farmer, Qianqian Li, et al.
NPJ Parkinson'S Disease|November 7, 2025
Mapping the developmental path for Parkinson's disease therapeuticsNeel T Dhruv, Sarah Robinson Schwartz, Christine Swanson-Fischer, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 22, 2023
The Effect of the COVID-19 Pandemic on HbA1c Testing: Prioritization of High-Risk Cases and Impact of Social DeprivationDavid Holland, Adrian H Heald, Fahmy F W Hanna, et al.
JMIR Research Protocols|May 5, 2023
Impact of California's Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline DataAna Florea, Joan A Casey, Keeve Nachman, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Pageof 13